“…Cancer patients have an intrinsically high risk of venous thrombosis, related to both the disease process itself and certain cancer treatments, [8] this risk being further increased by placement of a catheter or TIVAPS. [1] Several studies in cancer patients have investigated potential risk factors for TIVAPS-related complications, including the vein accessed [5,9,10] and patient age and gender [11,12], with somewhat conflicting results. Yildizeli analysis of paediatric patients, showed a higher risk of infection after TIVAPS implantation in younger patients.…”